These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6413814)

  • 1. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy.
    Haffner SM; Kushwaha RS; Foster DM; Applebaum-Bowden D; Hazzard WR
    Metabolism; 1983 Apr; 32(4):413-20. PubMed ID: 6413814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
    Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
    Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis.
    Taggart HM; Applebaum-Bowden D; Haffner S; Warnick GR; Cheung MC; Albers JJ; Chestnut CH; Hazzard WR
    Metabolism; 1982 Nov; 31(11):1147-52. PubMed ID: 6813637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol.
    Applebaum-Bowden D; Haffner SM; Hazzard WR
    Metabolism; 1987 Oct; 36(10):949-52. PubMed ID: 3657514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro.
    Taskinen MR; Nikkilä EA; Kuusi T; Tulikoura I
    Arteriosclerosis; 1983; 3(6):607-15. PubMed ID: 6651616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects.
    Taskinen MR; Glueck CJ; Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Robinson K; Kinnunen PJ; Kuusi T
    Atherosclerosis; 1980 Oct; 37(2):247-56. PubMed ID: 7426098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma high density lipoproteins HDL2, HDL3 and postheparin plasma lipases in relation to parameters of physical fitness.
    Kuusi T; Nikkilä EA; Saarinen P; Varjo P; Laitinen LA
    Atherosclerosis; 1982 Feb; 41(2-3):209-19. PubMed ID: 7066071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired metabolism of high density lipoprotein in uremic patients.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term stanozolol administration on serum lipoproteins in hepatic lipase deficiency.
    Bausserman LL; Saritelli AL; Herbert PN
    Metabolism; 1997 Sep; 46(9):992-6. PubMed ID: 9284885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition.
    Stubbe I; Hansson P; Gustafson A; Nilsson-Ehle P
    Metabolism; 1983 Dec; 32(12):1120-8. PubMed ID: 6417447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.
    Kuusi T; Ehnholm C; Viikari J; Härkönen R; Vartiainen E; Puska P; Taskinen MR
    J Lipid Res; 1989 Aug; 30(8):1117-26. PubMed ID: 2504859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity.
    Kantor MA; Bianchini A; Bernier D; Sady SP; Thompson PD
    Med Sci Sports Exerc; 1985 Aug; 17(4):462-5. PubMed ID: 4033402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.
    Taskinen MR; Kuusi T
    Atherosclerosis; 1986 Feb; 59(2):121-30. PubMed ID: 3083830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men.
    Hartung GH; Foreyt JP; Reeves RS; Krock LP; Patsch W; Patsch JR; Gotto AM
    Metabolism; 1990 Jan; 39(1):81-6. PubMed ID: 2104642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
    Kuusi T; Nikkilä EA; Tikkanen MJ; Sipinen S
    Atherosclerosis; 1985 Mar; 54(3):251-62. PubMed ID: 3158321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.
    Giada F; Baldo-Enzi G; Balocchi MR; Zuliani G; Baroni L; Fellin R
    Int J Sports Med; 1988 Aug; 9(4):270-4. PubMed ID: 3141306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel.
    Tikkanen MJ; Nikkilä EA; Kuusi T; Sipinen SU
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1113-7. PubMed ID: 7076794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.